Numis Securities Ltd Reaffirms Add Rating for Spire Healthcare Group PLC (SPI)
Spire Healthcare Group PLC (LON:SPI)‘s stock had its “add” rating restated by equities researchers at Numis Securities Ltd in a report issued on Thursday. They currently have a GBX 350 ($4.52) price target on the stock. Numis Securities Ltd’s price target suggests a potential upside of 34.51% from the company’s previous close.
Several other brokerages have also commented on SPI. Liberum Capital lowered Spire Healthcare Group PLC to a “hold” rating and decreased their price objective for the company from GBX 400 ($5.17) to GBX 370 ($4.78) in a report on Wednesday, July 19th. Credit Suisse Group reiterated an “underperform” rating on shares of Spire Healthcare Group PLC in a report on Friday, July 21st. Jefferies Group LLC increased their price objective on Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the company a “hold” rating in a report on Thursday, June 1st. Finally, Berenberg Bank increased their price objective on Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the company a “buy” rating in a report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. Spire Healthcare Group PLC presently has a consensus rating of “Hold” and an average price target of GBX 347 ($4.48).
Spire Healthcare Group PLC (LON SPI) traded up 3.17% on Thursday, hitting GBX 260.20. The stock had a trading volume of 3,350,487 shares. The stock’s 50-day moving average is GBX 327.79 and its 200 day moving average is GBX 332.90. The firm’s market capitalization is GBX 1.04 billion. Spire Healthcare Group PLC has a 1-year low of GBX 228.48 and a 1-year high of GBX 411.00.
Spire Healthcare Group PLC (LON:SPI) last posted its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The company had revenue of £481 million during the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. On average, equities research analysts predict that Spire Healthcare Group PLC will post $18.48 earnings per share for the current fiscal year.
Spire Healthcare Group PLC Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.